These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. How to predict adverse immune reactions induced by pharmaceutical compounds. Goldman M; Miller K; Bazin H Trends Biotechnol; 1995 Aug; 13(8):283-5. PubMed ID: 7662302 [No Abstract] [Full Text] [Related]
5. Immunogenicity of biopharmaceuticals in laboratory animals. Wierda D; Smith HW; Zwickl CM Toxicology; 2001 Feb; 158(1-2):71-4. PubMed ID: 11164995 [TBL] [Abstract][Full Text] [Related]
6. Prediction of adverse drug reactions using decision tree modeling. Hammann F; Gutmann H; Vogt N; Helma C; Drewe J Clin Pharmacol Ther; 2010 Jul; 88(1):52-9. PubMed ID: 20220749 [TBL] [Abstract][Full Text] [Related]
7. Tools to investigate and avoid drug-hypersensitivity in drug development. Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076 [TBL] [Abstract][Full Text] [Related]
8. Metabolic activation in drug allergies. Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988 [TBL] [Abstract][Full Text] [Related]
9. Immunological aspects of practolol toxicity. Amos HE Int J Immunopharmacol; 1979; 1(1):9-16. PubMed ID: 399251 [TBL] [Abstract][Full Text] [Related]
10. Primary Cell Phenotypic Screening Illuminates ADRs and AOPs. Bone AJ; Houck KA Cell Chem Biol; 2017 Jul; 24(7):781-782. PubMed ID: 28732198 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of the factors that influence morbidity among pharmaceutical workers]. Ponomarenko MS Farm Zh; 1979; (5):36-8. PubMed ID: 387437 [No Abstract] [Full Text] [Related]
13. Evaluation of ocular toxicity of two beta blocking drugs, carteolol and practolol, in beagle dogs. Tanaka N; Ohkawa T; Hiyama T; Nakajima A J Pharmacol Exp Ther; 1983 Feb; 224(2):424-30. PubMed ID: 6822964 [TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions: back to the future. Pirmohamed M; Park BK Br J Clin Pharmacol; 2003 May; 55(5):486-92. PubMed ID: 12755814 [No Abstract] [Full Text] [Related]
15. New technologies in drug metabolism and toxicity screening: organ-to-organ interaction. Bhushan A; Martucci NJ; Usta OB; Yarmush ML Expert Opin Drug Metab Toxicol; 2016 May; 12(5):475-7. PubMed ID: 26940609 [No Abstract] [Full Text] [Related]
16. Adverse drug reactions. Pirmohamed M; Breckenridge AM; Kitteringham NR; Park BK BMJ; 1998 Apr; 316(7140):1295-8. PubMed ID: 9554902 [No Abstract] [Full Text] [Related]
17. Drugs in control samples in nonclinical safety studies: a reconsideration. Zimmer D Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047 [No Abstract] [Full Text] [Related]
18. Iatrogenesis in the elderly. Drug-related problems. Stolley JM; Buckwalter KC; Fjordbak B; Bush S J Gerontol Nurs; 1991 Sep; 17(9):12-7. PubMed ID: 1880347 [TBL] [Abstract][Full Text] [Related]
19. The role of reactive drug metabolites in immune-mediated adverse drug reactions. Hess DA; Rieder MJ Ann Pharmacother; 1997 Nov; 31(11):1378-87. PubMed ID: 9391694 [TBL] [Abstract][Full Text] [Related]
20. Drug discovery: computer model predicts side effects. Kolaja K Nature; 2012 Jun; 486(7403):326-7. PubMed ID: 22722185 [No Abstract] [Full Text] [Related] [Next] [New Search]